Holen Sie sich die Stockscreener-App
15.88
0.75%
-0.12
Schlusskurs vom Vortag:
$16.00
Offen:
$15.91
24-Stunden-Volumen:
570.74K
Relative Volume:
0.19
Marktkapitalisierung:
$4.12B
Einnahmen:
$6.41B
Nettoeinkommen (Verlust:
$1.30B
KGV:
3.1508
EPS:
5.04
Netto-Cashflow:
$646.00M
1W Leistung:
+2.85%
1M Leistung:
+5.03%
6M Leistung:
-20.28%
1J Leistung:
-7.67%
1-Tages-Spanne:
$15.75
$16.10
1-Wochen-Bereich:
$15.24
$16.10
52-Wochen-Spanne:
$13.87
$23.10
Organon Co Stock (OGN) Company Profile
Firmenname
Organon Co
Sektor
Telefon
551-430-6000
Adresse
30 HUDSON STREET, JERSEY CITY
Vergleichen Sie OGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
15.89 | 4.12B | 6.41B | 1.30B | 646.00M | 5.04 |
|
LLY
Lilly Eli Co
|
785.48 | 707.77B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
86.88 | 380.36B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
142.66 | 342.94B | 87.70B | 14.68B | 19.03B | 6.05 |
|
ABBV
Abbvie Inc
|
175.89 | 309.57B | 55.53B | 5.12B | 15.62B | 2.88 |
|
MRK
Merck Co Inc
|
99.64 | 253.18B | 63.17B | 12.15B | 14.84B | 4.77 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-06 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-11-03 | Herabstufung | Goldman | Buy → Neutral |
| 2023-09-21 | Eingeleitet | Barclays | Overweight |
| 2023-03-16 | Eingeleitet | Raymond James | Outperform |
| 2022-10-14 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-01 | Eingeleitet | BofA Securities | Buy |
| 2021-07-22 | Eingeleitet | Citigroup | Buy |
| 2021-06-15 | Eingeleitet | JP Morgan | Neutral |
| 2021-06-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-06-10 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Organon Co Aktie (OGN) Neueste Nachrichten
Douglas Lane & Associates LLC Sells 260,842 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon continues to partner with VNPA for National Population Action Month - vietnamnews.vn
Organon (OGN) Outpaces Stock Market Gains: What You Should Know - MSN
Range Financial Group LLC Purchases New Stake in Organon & Co. (NYSE:OGN) - MarketBeat
(OGN) Long Term Investment Analysis - Stock Traders Daily
Organon & Co (OGN) Trading 3.21% Higher on Jan 4 - GuruFocus.com
Organon (OGN) Gains As Market Dips: What You Should Know - Yahoo Finance
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - MSN
Want $2,000 in Annual Dividends? Invest $11,000 in Each of These 3 Stocks. - The Motley Fool
Organon & Co (OGN) Shares Up 3.14% on Dec 31 - GuruFocus.com
Organon (OGN) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Principal Financial Group Inc. Decreases Position in Organon & Co. (NYSE:OGN) - MarketBeat
Organon & Co. (NYSE:OGN) Shares Acquired by Barclays PLC - MarketBeat
Organon Korea sales and customers lead named new head for Organon Malaysia - KBR
Geode Capital Management LLC Acquires 82,220 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
Organon CEO to Present at J.P. Morgan Healthcare Conference in January 2025 - StockTitan
Organon's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Canada
Organon's SWOT analysis: stock poised for growth amid challenges - Investing.com
FDA approves Organon’s VTAMA cream, 1% for the treatment for AD - Yahoo Finance
Organon & Co. (NYSE:OGN) Stock Price Down 3.8%Here's Why - MarketBeat
Organon’s steroid-free cream Vtama wins approval in atopic dermatitis - Endpoints News
Earnings Working Against Organon & Co.'s (NYSE:OGN) Share Price - Simply Wall St
Te Ahumairangi Investment Management Ltd Reduces Stake in Organon & Co. (NYSE:OGN) - MarketBeat
Organon's SWOT analysis: healthcare stock navigates growth amid challenges - Investing.com
125,654 Shares in Organon & Co. (NYSE:OGN) Purchased by Neo Ivy Capital Management - MarketBeat
Final Trades: Amazon, American Express and Organon - CNBC
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Fmr LLC Has $34.63 Million Stock Position in Organon & Co. (NYSE:OGN) - MarketBeat
Systematic Financial Management LP Has $726,000 Stock Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Organon & Co. announces board member resignation - Investing.com
Organon & Co. announces board member resignation By Investing.com - Investing.com South Africa
Weiss Asset Management LP Acquires New Stake in Organon & Co. (NYSE:OGN) - MarketBeat
(OGN) Trading Report - Stock Traders Daily
Readystate Asset Management LP Has $4.65 Million Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Jacobs Levy Equity Management Inc. Grows Stake in Organon & Co. (NYSE:OGN) - MarketBeat
Edgestream Partners L.P. Buys New Position in Organon & Co. (NYSE:OGN) - MarketBeat
Bridgewater Associates LP Takes Position in Organon & Co. (NYSE:OGN) - MarketBeat
Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune
Charles Schwab Investment Management Inc. Acquires 875,128 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Dynamic Technology Lab Private Ltd Invests $649,000 in Organon & Co. (NYSE:OGN) - MarketBeat
Finanzdaten der Organon Co-Aktie (OGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
0.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):